ArticleCureus2026
Management of Tuberculosis at El-Obeid Teaching Hospital During the Sudanese Armed Conflict: A Single-Center Descriptive Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) is a major global health issue, particularly in countries with armed conflict, a poor health-care system, and low-income populations. The purpose of this study was to describe the characteristics, diagnostic approaches, and reported barriers to healthcare access among TB patients managed at El-Obeid Teaching Hospital during three years of the armed conflict (2023 to 2026) in the war zone. METHODOLOGY: Between April 2023 and April 2026, a descriptive, prospective hospital-based study was conducted in El-Obeid, the capital of North Kordofan State, Sudan. The study included all patients diagnosed with TB in El-Obeid Teaching Hospital during the period from April 15, 2023, to April 15, 2026.
resultsThis study investigated 2193 TB patients, with 70% male patients and 30% female patients. The population was split 52% urban and 48% rural. Approximately 63% of patients began anti-TB medication later, within two to six months. Delays in treatment were caused by security concerns (42%), financial constraints (32%), a lack of healthcare resources (22%), and missed diagnoses (3%). The majority of patients reported a "new episode," followed by re-registered and multi-drug-resistant TB (MDR-TB) cases (90.6%, 8.8%, and 0.6%, respectively). Of the 13 MDR cases, 46% were new episodes, 38% were MDR, and 16% were reregistered. In 194 reregistered cases, 56% were recurring, while 44% were defaulters.
conclusionThe incidence rates of TB are increasing with the extent of war duration, particularly among men. Coinfection with HIV was significantly rising among women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.